Abstract
Critical illness is associated with multiple system organ dysfunction, and neurologic dysfunction is increasingly assessed and recognized. Neurologic dysfunction includes encephalopathy, cognitive, neuromuscular and psychiatric impairments, all of which can be severe and are associated with significant morbidity. Medical technological advances have improved central nervous system monitoring in critically ill patients, allowing quick and reliable diagnosis neurologic dysfunction such as delirium, sensory processing deficits, seizures, and encephalopathy to name a few. A number of neurologic evaluation tools are available to assess the neurologic status of critically ill patients both acutely, as well as longterm. Each tool provides unique information regarding neurologic status and has associated strengths and weakness. Identification of neurologic dysfunction allows for the development of working plans for prognostication, therapeutics, and rehabilitation that address the needs of each ICU survivor. This review focuses on the evaluation of neurologic sequelae during critical illness and long-term neurologic outcomes in survivors of critical illness.
Keywords: Cognitive sequelae, neurologic dysfunction, depression, quality of life, critical illness, ICU
Current Respiratory Medicine Reviews
Title: Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Volume: 3 Issue: 4
Author(s): Mary R. Suchyta and Ramona O. Hopkins
Affiliation:
Keywords: Cognitive sequelae, neurologic dysfunction, depression, quality of life, critical illness, ICU
Abstract: Critical illness is associated with multiple system organ dysfunction, and neurologic dysfunction is increasingly assessed and recognized. Neurologic dysfunction includes encephalopathy, cognitive, neuromuscular and psychiatric impairments, all of which can be severe and are associated with significant morbidity. Medical technological advances have improved central nervous system monitoring in critically ill patients, allowing quick and reliable diagnosis neurologic dysfunction such as delirium, sensory processing deficits, seizures, and encephalopathy to name a few. A number of neurologic evaluation tools are available to assess the neurologic status of critically ill patients both acutely, as well as longterm. Each tool provides unique information regarding neurologic status and has associated strengths and weakness. Identification of neurologic dysfunction allows for the development of working plans for prognostication, therapeutics, and rehabilitation that address the needs of each ICU survivor. This review focuses on the evaluation of neurologic sequelae during critical illness and long-term neurologic outcomes in survivors of critical illness.
Export Options
About this article
Cite this article as:
Suchyta R. Mary and Hopkins O. Ramona, Neurologic Sequelae in Critical Illness: Evaluation and Outcomes, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359904
DOI https://dx.doi.org/10.2174/157339807782359904 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Omega-3 and Renal Function in Older Adults
Current Pharmaceutical Design Optimizing the Management of Uncontrolled/Resistant Hypertension. The Importance of Sleep Apnoea Syndrome
Current Vascular Pharmacology Effect on Serum Uric Acid Levels of Drugs Prescribed for Indications other than Treating Hyperuricaemia
Current Pharmaceutical Design The Quality of Life of Thalassemic Patients: The Role of Endocrine Defect Compensation
Endocrine, Metabolic & Immune Disorders - Drug Targets Biologicals Dramatic Advances in the Treatment of Psoriasis
Current Pharmaceutical Design Function and Pharmacology of Spinally-Projecting Sympathetic Pre-Autonomic Neurones in the Paraventricular Nucleus of the Hypothalamus
Current Neuropharmacology Pomolic Acid Isolated from the Leaves of Licania pittieri Inhibits ADP-and Epinephrine-Induced Platelet Aggregation and has Hypotensive Effect on Rats
Current Bioactive Compounds GHB, GBL and 1,4-BD Addiction
Current Pharmaceutical Design Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry The Role of Procalcitonin in Sepsis and Septic Shock
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Platelets and Atherothrombosis: Causes, Targets and Treatments for Thrombosis
Current Medicinal Chemistry Paraneoplastic Neurological Syndromes - Diagnosis and Management
Current Pharmaceutical Design Modern Treatment of Infection and Ischaemia to Reduce Major Amputation in the Diabetic Foot
Current Pharmaceutical Design The Renin-Angiotensin System in the Mammalian Central Nervous System
Current Protein & Peptide Science Anti-Inflammatory Effects of Intravenous Anesthetics on Endotoxemia
Mini-Reviews in Medicinal Chemistry Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems
Current Medicinal Chemistry Fish Hydrolysates: A Regulatory Perspective of Bioactive Peptides
Protein & Peptide Letters Skeletal Effects of Central Nervous System Active Drugs: Anxiolytics, Sedatives, Antidepressants, Lithium and Neuroleptics
Current Drug Safety Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches
Current Pharmaceutical Design